Translating Disruptive New Approach Methodologies (NAMs) into Practice

Prazo de candidatura: 26/02/2026 · desde 03/12/2025

Expected Impact:This Challenge supports ambitions to maintain and strengthen the health sector in Europe. It will:Accelerate the development and validation of disruptive NAMs for biomedical applications, including medicinal products and medical technologiesSupport regulatory innovation by providing evidence-based recommendations for the assessment of safety, efficacy, and quality of human health products using NAMs.Enable citizens to benefit from novel technologies that have been assessed throug